Sarah N. Lauder
0000-0003-2561-6277
Publication & Citation Trends
Publications
95 total
Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events
Cited by 1
Semantic Scholar
Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study
Cited by 0
Semantic Scholar
Cytomegalovirus-induced T cell responses accelerate Alzheimer’s disease progression in mice
Cited by 2
Semantic Scholar
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4+ T cell activation. OA
Cited by 3
Semantic Scholar
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort) OA
Cited by 2
Semantic Scholar
Acquisition of suppressive function by conventional T cells limits anti-tumor immunity upon Treg depletion OA
Cited by 25
Semantic Scholar
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity PDF
Cited by 56
OpenAlex
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T Cells OA
Cited by 2
Semantic Scholar
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion OA
Cited by 16
Semantic Scholar
PI3K Isoform Immunotherapy for Solid Tumours.
Cited by 7
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(29)
Immune Cell Function and Interaction
(25)
CAR-T cell therapy research
(25)
Immunotherapy and Immune Responses
(22)
Cell Adhesion Molecules Research
(19)
Affiliations
University of Pittsburgh
University Hospital of Wales
Hammersmith Hospital
Centre for Immunity, Infection and Evolution
Immune Regulation (United Kingdom)